Erlocip Erlotinib 150mg Tablet

Product Name: Erlotinib 150mg Tablet
Brand Name: Erlotinib
Composition: Erlotinib (150 mg)
Form: Tablet
Dosage Form: Oral
Dose/Strength: 150 mg
Packaging Size: 30 Tablets per Strip
Packaging Type: Strip
Manufacturer: Cipla
Prescription Status: Prescription Only
Form of Medicine: Allopathic
Usage/Application: As directed by a physician

Description:
Erlotinib 150mg Tablet is an oral cancer medication used in the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs) and works by blocking the activity of a specific protein (epidermal growth factor receptor, EGFR) that promotes cancer cell growth.

Erlotinib is most effective in patients with EGFR mutation-positive tumors and is often prescribed as a first-line or maintenance therapy in advanced stages of cancer.

Indications:

• Non-small cell lung cancer (NSCLC)

• Locally advanced or metastatic pancreatic cancer (in combination with gemcitabine)

Key Features:

• Each tablet contains 150 mg of Erlotinib

• Manufactured by Cipla, a leading global pharmaceutical company

• Convenient 30-tablet strip packaging

• Used as part of targeted cancer therapy, offering specificity in treatment